Literature DB >> 31688869

PrEP Drug Is Approved for Some Patients but Not for Others.

Rebecca Voelker.   

Abstract

Entities:  

Year:  2019        PMID： 31688869     DOI： 10.1001/jama.2019.17814

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

Review 1.  A Bayesian averted infection framework for PrEP trials with low numbers of HIV infections: application to the results of the DISCOVER trial.

Authors:  David V Glidden; Oliver T Stirrup; David T Dunn
Journal:  Lancet HIV       Date:  2020-11       Impact factor: 12.767

2.  LGBTQ+ health research guides at North American health sciences libraries: a survey and content analysis.

Authors:  Gregg A Stevens; Francisco J Fajardo
Journal:  J Med Libr Assoc       Date:  2021-07-01

3.  Navigating Human Immunodeficiency Virus and Primary Care Concerns Specific to the Transgender and Gender-Nonbinary Population.

Authors:  Mark Lieber; Matthew M Hamill; Paul Pham; Elyse Pine; Jill Crank; Maunank Shah
Journal:  Open Forum Infect Dis       Date:  2022-03-23       Impact factor: 3.835

4.  Towards Precision Medicine: Inclusion of Sex and Gender Aspects in COVID-19 Clinical Studies-Acting Now before It Is Too Late-A Joint Call for Action.

Authors:  Evelyne Bischof; Sabine Oertelt-Prigione; Rosemary Morgan; Sabra L Klein
Journal:  Int J Environ Res Public Health       Date:  2020-05-25       Impact factor: 3.390
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.